Millendo Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating income was USD 10.604 million compared to USD 10.160 million a year ago. Net loss was USD 10.672 million compared to USD 9.871 million a year ago. Basic loss per share was USD 0.56 compared to USD 0.74 a year ago. For the half year, operating income was USD 22.739 million compared to USD 20.817 million a year ago. Net loss was USD 22.670 million compared to USD 20.237 million a year ago. Basic loss per share was USD 1.21 compared to USD 1.51 a year ago.